ADAM C DERBYSHIRE Insider Trading $SLXP SALIX PHARMACEUTICALS LTD
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ADAM C DERBYSHIRE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ADAM C DERBYSHIRE. ADAM C DERBYSHIRE is EVP Finance/CFO in SALIX PHARMACEUTICALS LTD ($SLXP) and Sr. VP Finance/CFO in SALIX PHARMACEUTICALS LTD ($SLXP).
ADAM C DERBYSHIRE in SALIX PHARMACEUTICALS LTD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ADAM C DERBYSHIRE: EVP Finance/CFO, Sr. VP Finance/CFO
Holdings: 133,990 shares
Latest Transaction: Jul 06 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ADAM C DERBYSHIRE in SALIX PHARMACEUTICALS LTD
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2011 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 39.83 | 11,242 | 447,769 | 133,990 | 145.2 K to 134 K (-7.74 %) |
| May 04 2011 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Grant | A | 0.00 | 25,955 | 0 | 145,232 | 119.3 K to 145.2 K (+21.76 %) |
| Jul 21 2010 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Grant | A | 0.00 | 19,520 | 0 | 119,277 | 99.8 K to 119.3 K (+19.57 %) |
| Jul 06 2010 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 39.03 | 8,614 | 336,204 | 99,757 | 108.4 K to 99.8 K (-7.95 %) |
| Dec 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 0 | |
| Dec 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 23.10 | 5,000 | 115,500 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Dec 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Nov 30 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 10,000 | |
| Nov 30 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 23.58 | 5,000 | 117,900 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Nov 30 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Dec 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 5,000 | |
| Dec 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 23.37 | 5,000 | 116,850 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Dec 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Nov 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 20,000 | |
| Nov 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 20.12 | 5,000 | 100,600 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Nov 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Nov 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 15,000 | |
| Nov 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 21.05 | 5,000 | 105,250 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Nov 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Oct 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 30,000 | |
| Oct 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.79 | 5,000 | 98,950 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Oct 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 25,000 | |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.85 | 84 | 1,667 | 108,371 | 108.5 K to 108.4 K (-0.08 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.81 | 200 | 3,962 | 108,455 | 108.7 K to 108.5 K (-0.18 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.80 | 200 | 3,960 | 108,655 | 108.9 K to 108.7 K (-0.18 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.78 | 300 | 5,934 | 108,855 | 109.2 K to 108.9 K (-0.27 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.77 | 96 | 1,898 | 109,155 | 109.3 K to 109.2 K (-0.09 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.76 | 99 | 1,956 | 109,251 | 109.4 K to 109.3 K (-0.09 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.75 | 99 | 1,955 | 109,350 | 109.4 K to 109.4 K (-0.09 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.74 | 100 | 1,974 | 109,449 | 109.5 K to 109.4 K (-0.09 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.73 | 100 | 1,973 | 109,549 | 109.6 K to 109.5 K (-0.09 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.72 | 404 | 7,967 | 109,649 | 110.1 K to 109.6 K (-0.37 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.71 | 300 | 5,913 | 110,053 | 110.4 K to 110.1 K (-0.27 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.70 | 800 | 15,760 | 110,353 | 111.2 K to 110.4 K (-0.72 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.69 | 805 | 15,850 | 111,153 | 112 K to 111.2 K (-0.72 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.66 | 200 | 3,932 | 111,958 | 112.2 K to 112 K (-0.18 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.62 | 600 | 11,772 | 112,158 | 112.8 K to 112.2 K (-0.53 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.60 | 613 | 12,015 | 112,758 | 113.4 K to 112.8 K (-0.54 %) |
| Nov 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Oct 23 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 35,000 | |
| Oct 23 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 21.00 | 5,000 | 105,000 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Oct 23 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Oct 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 40,000 | |
| Oct 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 22.89 | 5,000 | 114,450 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Oct 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Oct 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 45,000 | |
| Oct 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 23.89 | 5,000 | 119,450 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Oct 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Oct 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 50,000 | |
| Oct 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 21.04 | 5,000 | 105,200 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Oct 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Sep 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 55,000 | |
| Sep 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 20.73 | 5,000 | 103,650 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Sep 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 113,371 | 108.4 K to 113.4 K (+4.61 %) |
| Sep 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 60,000 | |
| Sep 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 19.80 | 5,000 | 99,000 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Sep 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 109,371 | 104.4 K to 109.4 K (+4.79 %) |
| Sep 09 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 5,000 | 5,667 | 65,000 | |
| Sep 09 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.92 | 5,000 | 64,600 | 108,371 | 113.4 K to 108.4 K (-4.41 %) |
| Sep 09 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 5,000 | 5,667 | 109,371 | 104.4 K to 109.4 K (+4.79 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 70,000 | |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 71,000 | |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 72,000 | |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.45 | 1,000 | 12,450 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.24 | 100 | 1,224 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.22 | 900 | 10,998 | 108,471 | 109.4 K to 108.5 K (-0.82 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.01 | 1,000 | 12,010 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Sep 04 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 76,000 | |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 77,000 | |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 78,000 | |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.85 | 221 | 2,840 | 108,371 | 108.6 K to 108.4 K (-0.20 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.84 | 700 | 8,988 | 108,592 | 109.3 K to 108.6 K (-0.64 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.80 | 79 | 1,011 | 109,292 | 109.4 K to 109.3 K (-0.07 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.70 | 1,000 | 12,700 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.95 | 1,000 | 12,950 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 27 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 73,000 | |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 74,000 | |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 75,000 | |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.64 | 100 | 1,264 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.62 | 100 | 1,262 | 108,471 | 108.6 K to 108.5 K (-0.09 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.60 | 200 | 2,520 | 108,571 | 108.8 K to 108.6 K (-0.18 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.58 | 600 | 7,548 | 108,771 | 109.4 K to 108.8 K (-0.55 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.50 | 1,000 | 12,500 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.88 | 1,000 | 12,880 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Sep 01 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 79,000 | |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 80,000 | |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 81,000 | |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.62 | 1,000 | 12,620 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.89 | 1,000 | 12,890 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.70 | 1,000 | 12,700 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 82,000 | |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 83,000 | |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 84,000 | |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.72 | 1,000 | 12,720 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.38 | 1,000 | 12,380 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.35 | 1,000 | 12,350 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 19 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 85,000 | |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 86,000 | |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 87,000 | |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.66 | 1,000 | 12,660 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.57 | 400 | 5,028 | 108,371 | 108.8 K to 108.4 K (-0.37 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.56 | 600 | 7,536 | 108,771 | 109.4 K to 108.8 K (-0.55 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.59 | 1,000 | 12,590 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 14 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 91,000 | |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 92,000 | |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 93,000 | |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.51 | 1,000 | 12,510 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.33 | 1,000 | 12,330 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.10 | 1,000 | 12,100 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 88,000 | |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 89,000 | |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 90,000 | |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.60 | 1,000 | 12,600 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.49 | 1,000 | 12,490 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.33 | 1,000 | 12,330 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 11 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 94,000 | |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 95,000 | |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 96,000 | |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.22 | 1,000 | 12,220 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.27 | 1,000 | 12,270 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.67 | 1,000 | 12,670 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
| Aug 03 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
| Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 97,000 |